Envestnet Asset Management
KRTX

Envestnet Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Envestnet Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,447
Closed -$7.74M – 4321
2023
Q4 		$7.74M Buy
24,447
+4,267
+21% +$829K ﹤0.01% 1602
2023
Q3 		$3.41M Buy
20,180
+12,342
+157% +$2.32M ﹤0.01% 2058
2023
Q2 		$1.7M Sell
7,838
-106
-1% -$22.7K ﹤0.01% 2373
2023
Q1 		$1.44M Buy
7,944
+1,878
+31% +$359K ﹤0.01% 2409
2022
Q4 		$1.19M Buy
6,066
+1,528
+34% +$328K ﹤0.01% 2504
2022
Q3 		$1.02M Buy
4,538
+2,110
+87% +$427K ﹤0.01% 2555
2022
Q2 		$307K Buy
+2,428
New +$279K ﹤0.01% 3339
2021
Q2 		– Sell
-1,838
Closed -$221K – 3714
2021
Q1 		$221K Buy
+1,838
New +$208K ﹤0.01% 3294

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Envestnet Asset Management's KRTX Position: Q1 2024 in Review

Envestnet Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 24,447 shares — an estimated $7.74M sold.

Envestnet Asset Management first reported a position in KRTX in Q1 2021 and held it in 8 quarters. The position peaked at $7.74M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Envestnet Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 24,447 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $7.74M.
  • Envestnet Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Envestnet Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $7.74M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Envestnet Asset Management's 13F filing for Q1 2024, filed 13 May 2024.